HEADER CHAPERONE 29-SEP-17 6ELN TITLE ESTIMATION OF RELATIVE DRUG-TARGET RESIDENCE TIMES BY RANDOM TITLE 2 ACCELERATION MOLECULAR DYNAMICS SIMULATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HEAT SHOCK 86 KDA,HSP86,LIPOPOLYSACCHARIDE-ASSOCIATED COMPND 5 PROTEIN 2,LPS-ASSOCIATED PROTEIN 2,RENAL CARCINOMA ANTIGEN NY-REN-38; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSP90AA1, HSP90A, HSPC1, HSPCA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CHAPERONE PROTEIN, ATP BINDING, CHAPERONE EXPDTA X-RAY DIFFRACTION AUTHOR D.MUSIL,M.LEHMANN,H.-M.EGGENWEILER REVDAT 2 18-JUL-18 6ELN 1 JRNL REVDAT 1 30-MAY-18 6ELN 0 JRNL AUTH D.B.KOKH,M.AMARAL,J.BOMKE,U.GRADLER,D.MUSIL,H.P.BUCHSTALLER, JRNL AUTH 2 M.K.DREYER,M.FRECH,M.LOWINSKI,F.VALLEE,M.BIANCIOTTO,A.RAK, JRNL AUTH 3 R.C.WADE JRNL TITL ESTIMATION OF DRUG-TARGET RESIDENCE TIMES BY TAU-RANDOM JRNL TITL 2 ACCELERATION MOLECULAR DYNAMICS SIMULATIONS. JRNL REF J CHEM THEORY COMPUT V. 14 3859 2018 JRNL REFN ISSN 1549-9626 JRNL PMID 29768913 JRNL DOI 10.1021/ACS.JCTC.8B00230 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 83.8 REMARK 3 NUMBER OF REFLECTIONS : 32864 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 1623 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 24.70 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 885 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2882 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 834 REMARK 3 BIN R VALUE (WORKING SET) : 0.2893 REMARK 3 BIN FREE R VALUE : 0.2689 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.76 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 51 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1627 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 299 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.77 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.91810 REMARK 3 B22 (A**2) : -1.55340 REMARK 3 B33 (A**2) : -0.36470 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.240 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.099 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.094 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.090 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.088 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1685 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2276 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 596 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 46 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 238 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1685 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 229 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2246 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.29 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.82 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 65.0683 30.3704 29.8349 REMARK 3 T TENSOR REMARK 3 T11: -0.0276 T22: -0.0148 REMARK 3 T33: -0.0462 T12: 0.0004 REMARK 3 T13: -0.0125 T23: -0.0169 REMARK 3 L TENSOR REMARK 3 L11: 0.8373 L22: 0.4844 REMARK 3 L33: 0.6105 L12: -0.1154 REMARK 3 L13: -0.1177 L23: 0.0731 REMARK 3 S TENSOR REMARK 3 S11: 0.0305 S12: 0.0026 S13: -0.0254 REMARK 3 S21: -0.0280 S22: -0.0162 S23: 0.0158 REMARK 3 S31: 0.0120 S32: 0.0432 S33: -0.0143 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ELN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-SEP-17. REMARK 100 THE DEPOSITION ID IS D_1200006820. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-MAR-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : D*TREK 8.0SSI REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32991 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.580 REMARK 200 RESOLUTION RANGE LOW (A) : 36.380 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 80.8 REMARK 200 DATA REDUNDANCY : 2.920 REMARK 200 R MERGE (I) : 0.04500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 15.6 REMARK 200 DATA REDUNDANCY IN SHELL : 1.21 REMARK 200 R MERGE FOR SHELL (I) : 0.25700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NA-CACODYLATE, PH 6.5 30% PEG8000 0.2 REMARK 280 M AMMONIUM SULFATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 32.83550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 44.71350 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 50.07350 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 32.83550 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 44.71350 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 50.07350 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 32.83550 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 44.71350 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 50.07350 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 32.83550 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 44.71350 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 50.07350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 320 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 110 53.84 -94.48 REMARK 500 ALA A 166 -142.31 63.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue P4A A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 303 DBREF 6ELN A 17 223 UNP P07900 HS90A_HUMAN 17 223 SEQRES 1 A 207 VAL GLU THR PHE ALA PHE GLN ALA GLU ILE ALA GLN LEU SEQRES 2 A 207 MET SER LEU ILE ILE ASN THR PHE TYR SER ASN LYS GLU SEQRES 3 A 207 ILE PHE LEU ARG GLU LEU ILE SER ASN SER SER ASP ALA SEQRES 4 A 207 LEU ASP LYS ILE ARG TYR GLU SER LEU THR ASP PRO SER SEQRES 5 A 207 LYS LEU ASP SER GLY LYS GLU LEU HIS ILE ASN LEU ILE SEQRES 6 A 207 PRO ASN LYS GLN ASP ARG THR LEU THR ILE VAL ASP THR SEQRES 7 A 207 GLY ILE GLY MET THR LYS ALA ASP LEU ILE ASN ASN LEU SEQRES 8 A 207 GLY THR ILE ALA LYS SER GLY THR LYS ALA PHE MET GLU SEQRES 9 A 207 ALA LEU GLN ALA GLY ALA ASP ILE SER MET ILE GLY GLN SEQRES 10 A 207 PHE GLY VAL GLY PHE TYR SER ALA TYR LEU VAL ALA GLU SEQRES 11 A 207 LYS VAL THR VAL ILE THR LYS HIS ASN ASP ASP GLU GLN SEQRES 12 A 207 TYR ALA TRP GLU SER SER ALA GLY GLY SER PHE THR VAL SEQRES 13 A 207 ARG THR ASP THR GLY GLU PRO MET GLY ARG GLY THR LYS SEQRES 14 A 207 VAL ILE LEU HIS LEU LYS GLU ASP GLN THR GLU TYR LEU SEQRES 15 A 207 GLU GLU ARG ARG ILE LYS GLU ILE VAL LYS LYS HIS SER SEQRES 16 A 207 GLN PHE ILE GLY TYR PRO ILE THR LEU PHE VAL GLU HET P4A A 301 22 HET SO4 A 302 5 HET SO4 A 303 5 HETNAM P4A 4-[4-(4-METHOXYPHENYL)-5-METHYL-1H-PYRAZOL-3- HETNAM 2 P4A YL]BENZENE-1,3-DIOL HETNAM SO4 SULFATE ION HETSYN P4A 3-(2,4-DIHYDROXYPHENYL)-4-(4-METHOXYPHENYL)-5-METHYL- HETSYN 2 P4A 1H-PYRAZOLE FORMUL 2 P4A C17 H16 N2 O3 FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 HOH *299(H2 O) HELIX 1 AA1 GLN A 23 THR A 36 1 14 HELIX 2 AA2 ASN A 40 GLU A 42 5 3 HELIX 3 AA3 ILE A 43 LEU A 64 1 22 HELIX 4 AA4 THR A 65 ASP A 71 5 7 HELIX 5 AA5 THR A 99 ASN A 105 1 7 HELIX 6 AA6 ASN A 106 THR A 109 5 4 HELIX 7 AA7 ILE A 110 ALA A 124 1 15 HELIX 8 AA8 ASP A 127 GLY A 135 5 9 HELIX 9 AA9 VAL A 136 LEU A 143 5 8 HELIX 10 AB1 GLU A 192 LEU A 198 5 7 HELIX 11 AB2 GLU A 199 SER A 211 1 13 SHEET 1 AA1 8 GLU A 18 ALA A 21 0 SHEET 2 AA1 8 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20 SHEET 3 AA1 8 TYR A 160 SER A 164 -1 N ALA A 161 O ARG A 173 SHEET 4 AA1 8 ALA A 145 LYS A 153 -1 N VAL A 150 O TRP A 162 SHEET 5 AA1 8 GLY A 183 LEU A 190 -1 O ILE A 187 N THR A 149 SHEET 6 AA1 8 THR A 88 ASP A 93 -1 N ILE A 91 O VAL A 186 SHEET 7 AA1 8 ILE A 78 ASN A 83 -1 N ILE A 81 O THR A 90 SHEET 8 AA1 8 ILE A 218 LEU A 220 1 O THR A 219 N LEU A 80 SITE 1 AC1 15 LEU A 48 ASN A 51 ALA A 55 LYS A 58 SITE 2 AC1 15 ASP A 93 ILE A 96 GLY A 97 MET A 98 SITE 3 AC1 15 LEU A 107 GLY A 108 THR A 184 VAL A 186 SITE 4 AC1 15 SO4 A 302 HOH A 453 HOH A 493 SITE 1 AC2 11 ASP A 57 LYS A 58 GLY A 108 P4A A 301 SITE 2 AC2 11 HOH A 419 HOH A 430 HOH A 450 HOH A 456 SITE 3 AC2 11 HOH A 472 HOH A 520 HOH A 577 SITE 1 AC3 2 HIS A 210 HOH A 495 CRYST1 65.671 89.427 100.147 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015227 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011182 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009985 0.00000